RALOXIFENE GxP Raloxifene hydrochloride 60 mg tablets, blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

raloxifene hydrochloride, Quantity: 60 mg

제공처:

MedTAS Pty Ltd

INN (International Name):

Raloxifene hydrochloride

약제 형태:

Tablet, film coated

구성:

Excipient Ingredients: microcrystalline cellulose; crospovidone; magnesium stearate; glycine; colloidal anhydrous silica; polysorbate 80; povidone; titanium dioxide; hypromellose; Carnauba Wax; macrogol 400

관리 경로:

Oral

패키지 단위:

28 tablets

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

Raloxifene is indicated for the prevention and treatment of osteoporosis in post-menopausal women.,Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women with osteoporosis.Raloxifene is indicated for the reduction in the risk of invasive breast cancer in postmenopausal women at high risk of invasive breast cancer.

제품 요약:

Visual Identification: White to off-white, oval, biconvex, film coated tablets with 'C' on one side and '12' on other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2014-01-14